Peter Molony

Peter Molony

Auto-generated profile, based on publicly available information

Peter Molony

Laboratory Medicine Program, University Health Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Oral Oncology
Verified
Journal Article
Closed access
PMPeter Molony
Peter Molony
RWReiltin Werner
Reiltin Werner
CMCara M Martin
Cara M Martin
DCDeirdre Callanan
Deirdre Callanan
INIrene Nauta
Irene Nauta
LFLinda Feeley
Linda Feeley

24 September 2019 in Head and Neck Pathology
Verified
Journal Article
Closed access
PDF file
PMPeter Molony
Peter Molony
RWReiltin Werner
Reiltin Werner
CMCara Martin
Cara Martin
DCDeirdre Callanan
Deirdre Callanan
PSPatrick Sheahan
Patrick Sheahan
LFLinda Feeley
Linda Feeley

17 January 2022 in Cytogenetic and Genome Research
Verified
Journal Article
Open access
PDF file
PMPeter Molony
Peter Molony
ASAdam Campbell Smith
Adam Campbell Smith
SSShamini Selvarajah
Shamini Selvarajah
Ali SakhdariAli Sakhdari
Ali Sakhdari
Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U) is a poorly characterized entity among overlap myeloid syndromes. Recent studies have shown heterogeneous mutational profiles in this group being able to subclassify them into entities closely related to the more well-established disorders under the umbrella term of the MDS/MPN group. Recurrent cytogenetic alterations are, nonetheless, rare in MDS/MPN-U. Here, for the first time, we report a case of MDS/MPN-U with a t(X;17)(q28;q21) chromosomal rearrangement leading to the KANSL1-MTCP1 fusion gene.